Navigation Links
Generic drugs key to US overseas HIV relief
Date:7/9/2012

PROVIDENCE, R.I. [Brown University] The President's Emergency Plan for AIDS Relief (PEPfAR) began in 2003 with good intentions, but it was not until the U.S. government's massive overseas public health campaign adopted generic drugs that it became a success, according to a new article by Brown University researchers in the July issue of the journal Health Affairs. Nearly a decade later, expanding the availability of generics remains urgent, especially as doctors in the field encounter resistance to first-line treatment regimens.

"By 2002 generic drugs had been shown to work, so there was not a question of whether they were efficacious," said Kartik Venkatesh, an M.D./Ph.D. graduate student and the paper's lead author. "So then it was a question of how do we expand access to treatment so that more than 5 to 10 percent of those in need of treatment were getting it. Now two out of three individuals who need treatment in the 15 PEPfAR countries are getting it."

That's because the program, which primarily bought proprietary medicines from major U.S. manufacturers in the early years, eventually made the transition to much cheaper generics, said Venkatesh who will speak about the paper as part of a Health Affairs briefing July 10 that features Nils Daulaire, director of global health affairs in the Department of Health and Human Services, and Eric Goosby, U.S. global AIDS coordinator.

Generics slashed the program's costs, allowing it to vastly expand care delivery. In their review article, Venkatesh and his co-authors cite data that PEPfAR has reduced its annual per person spending on antiretroviral medicines to $300 this year from $1,100 in 2005.

PEPfAR, launched by President George W. Bush and then reauthorized by President Obama, is a multibillion-dollar effort to deliver HIV treatment and other related health services to people in 15 developing nations, including 12 in sub-Saharan Africa.

Early on, the program d
'/>"/>

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Plavixs New Generic Status Could Be Boon for Patients
2. FDA Approves Generic Versions of Plavix
3. Pharmacy Robots Linked to Bacterial Contamination of Drugs
4. Penn study cautions use of drugs to block niacin flush
5. Urinary Incontinence Drugs May Be More Trouble Than Theyre Worth
6. Discovery could help to develop drugs for organ transplant and cancer patients
7. Not taking gastroprotective drugs prescribed with anti-inflammatory medicines
8. Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment
9. Weight-Loss Surgery Beat Drugs for Cutting Diabetes in Very Obese
10. Seniors Stop Taking Heart Drugs In Medicare Donut Hole
11. New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , ... August 29, 2015 , ... Rio Salado ... learning and the student experience as part of the EDUCAUSE - Next Generation Learning ... . , This is the third Breakthrough Models Incubator hosted by EDUCAUSE ...
(Date:8/28/2015)... ... August 28, 2015 , ... Approximately 2,000 United Methodists ... celebrate children helping children, a thank you to the many creative and generous ... to the United Methodist initiative to end malaria deaths. , The Columbus Zoo ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... With the ... concert returned for the second year to the Adams County Fairgrounds in Mendon, IL ... held to raise money to support music education in the underfunded school districts of ...
(Date:8/28/2015)... ... ... As reported by Medical Daily on August 22 , Cellfina, a ... for two years, the longest of any cellulite reduction system currently on the market. ... effective solution for their cellulite, according to Dr. Robert Weiss, director of the premier ...
(Date:8/28/2015)... Manistee, Michigan (PRWEB) , ... August 28, 2015 ... ... or alcohol abuse, or those who might personally be struggling with chemical dependency, ... blog post from Best Drug Rehabilitation, a results-driven holistic treatment center for addiction ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3
... Reporter , MONDAY, Nov. 22 (HealthDay News) -- Diabetes ... a new study shows. The research, conducted at ... had a much higher risk of developing diabetes, and ... depression, compared to healthy study participants. "This study ...
... Minn. -- A new Mayo Clinic study ... low-grade brain tumors (gliomas) ( http://www.mayoclinic.org/brain-tumors/ ) ... the tumor have an increased chance of ... possible, adding radiation therapy to a less ...
... helping researchers learn whether more muscle improves the cardiovascular ... ways to counteract the unhealthy effects of fat," said ... of Georgia Vascular Biology Center and co-director of MCG,s ... the risk for cardiovascular disease as well as diabetes, ...
... Reinberg HealthDay Reporter , MONDAY, Nov. 22 (HealthDay ... taken off the market, emergency rooms treat less than half ... reactions to the drugs, a new U.S. government study shows. ... for children aged 2 and under took effect in October ...
... Biochemist and protein crystallographer Dr. Oliver Daumke of the ... has won the "Bayer Early Excellence in Science Award ... prize worth EUR 10,000 for his contributions to the ... proteins next spring in Berlin. Together with him, two ...
... , MONDAY, Nov. 22 (HealthDay News) -- Infants with Down syndrome ... risk for heart and lung disorders that increase their chances of ... medical records of more than 50,000 very low birth weight (VLBW) ... They found that among this group of babies, those born with ...
Cached Medicine News:Health News:Diabetes, Depression Can Be Two-Way Street 2Health News:Diabetes, Depression Can Be Two-Way Street 3Health News:Mayo Clinic study finds aggressive surgery is best for children with brain tumors 2Health News:Fat yet muscular mouse provides clues to improving cardiovascular health 2Health News:Kids' ER Visits Down After Cold Medicine Withdrawal 2Health News:Kids' ER Visits Down After Cold Medicine Withdrawal 3Health News:Tiniest Newborns With Down Syndrome Face Other Health Risks 2
(Date:8/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/jq34zf/investigation ... Report on China,s Tobramycin Market, 2010-2019" report to ... whose eye drop and ointment are the most common ... inflammation caused by eye infection. Currently, dozens of enterprises ... produce tobramycin, among which the Top 5 are s.a. ...
(Date:8/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/rktnl9/investigation ... "Investigation Report on China,s Insulin Aspart Market, 2010-2019" ... by Novo Nordisk, insulin aspart (under the trade ... the treatment of diabetes. Compared with human insulin, ... starts working fast and reports higher peak of ...
(Date:8/28/2015)... , Aug. 28, 2015  IP Shakti, LLC, today announced ... Logo - ... "Our new corporate identity signifies our transformation into a ... predictive analytics platform for patent claim validity." ... of the proprietary AIA Shield™ platform, the Company commenced a ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2
... CALGARY, June 20, 2007 /PRNewswire-FirstCall/ - SemBioSys,Genetics ... portfolio of,therapeutic proteins for metabolic and cardiovascular ... a scientific poster and,abstract at the 67th ... in Chicago. The Company's poster will disclose,recent ...
... Follow,Presentation, DANBURY, Conn., June 20, 2007 /PRNewswire-FirstCall/ -- ... of its,leading product candidate, VIAject(TM), at the 67th ... held in,Chicago, June 22 through June 26. , ... place on June 22,from 4:15 - 6:15pm CST, ...
Cached Medicine Technology:SemBioSys to present new data at American Diabetes Association,annual meeting 2SemBioSys to present new data at American Diabetes Association,annual meeting 3Biodel Inc. to Present VIAject Clinical Progress at the 2007,American Diabetes Association Meeting 2Biodel Inc. to Present VIAject Clinical Progress at the 2007,American Diabetes Association Meeting 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: